Form 4: Serina Therapeutics CEO Steven Ledger Acquires Stock Options
SEC Form 4
Serina Therapeutics CEO Steven Ledger reports acquisition of stock options and disposal of shares.
Summary
- On September 9, 2024, Steven Ledger, CEO of Serina Therapeutics, acquired 376,388 stock options with an exercise price of $7.40.
- These options vest in installments starting March 9, 2025, and will be fully vested by the fourth anniversary of the grant date, contingent upon continued service.
- Ledger also disposed of 490,350 common stock shares.
- Following these transactions, Ledger directly owns 490,350 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock options and share disposal, with neutral implications.
Future Outlook
The stock options vest over a four-year period, contingent on the Reporting Person's continued service to the Issuer.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders are informed about changes in the CEO's beneficial ownership of company securities.
Key Dates
| Date | Description |
|---|---|
| 09/09/2024 | Date of stock option acquisition and share disposal. |
| 03/09/2025 | First vesting date for 12.5% of the stock options. |
| 09/09/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.